News

Soleno Therapeutics Announces $16.5 Million Private Placement

December 19, 2018

Financing Led by Abingworth; Andrew Sinclair , Partner, to Join Soleno’s Board Funding to Support ...

Read More

Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018

November 15, 2018

DCCR treatment resulted in statistically significant decreases in body fat in subjects with Prader-Willi Syndrome ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results

November 15, 2018

REDWOOD CITY, Calif. , Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More
Soleno – Home